Table 2:

Types of regimens of menopausal hormone therapy used

RegimenNo. (%) of treatments*
Transdermal estrogen48 846 (62.3)
Without progestagen9 488 (12.1)
With progesterone20 534 (26.2)
With pregnane derivative6 449 (8.2)
With norpregnane derivative11 370 (14.5)
With testosterone derivative518 (0.7)
With other progestagen487 (0.6)
Oral estrogen22 880 (29.2)
Estradiol21 498 (27.4)
 Without progestagen1 713 (2.2)
 With progesterone4 940 (6.3)
 With pregnane derivative7 121 (9.1)
 With norpregnane derivative2 775 (3.5)
 With testosterone derivative4 822 (6.1)
 With other progestagen127 (0.2)
Oral equine estrogen1 382 (1.8)
 Without progestagen585 (0.7)
 With progesterone219 (0.3)
 With pregnane derivative311 (0.4)
 With norpregnane derivative193 (0.2)
 With testosterone derivative45 (0.1)
 With other progestagen29 (0.04)
Other estrogen6 709 (8.6)

  • ↵* Each course of menopausal hormone therapy is counted separately. The total courses of treatment was 78 435 among 45 984 women.